Cansino Biologics Placement - Past Deal Didn't Do Well, Losing the Vaccine Race
Lilly Asia is looking to raise around US$180m via selling a 6% stake in CanSino Biologics Inc (6185 HK)'s H-shares. Lilly Asia last sold its stake...
395 Views
China Healthcare Weekly (Oct.9)
This insight summarized the important industry viewpoints, news of listed healthcare companies and capital market review for the last week of China...
220 Views
JHBP Holdings (Genor Biopharma) IPO Initiation: Hunting for a Cure
$ Genor Biopharma is a biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. Its drug candidates...
440 Views
S&P 500 Technical Appraisal and Support Levels
S&P 500 Potential Support Levels. Current logical support levels we are monitoring include the December 2018 low of 2,346 and prior resistance...
403 Views